1 – 15 of 15
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis
(
- Contribution to journal › Article
- 2021
-
Mark
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study
(
- Contribution to journal › Article
- 2020
-
Mark
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk : Results from the EPIC cohort
(
- Contribution to journal › Article
- 2019
-
Mark
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort
(
- Contribution to journal › Article
-
Mark
Combined effects of smoking and HPV16 in oropharyngeal cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Human Papillomavirus 16 E6 Antibodies in Individuals Without Diagnosed Cancer: A Pooled Analysis.
(
- Contribution to journal › Article
- 2014
-
Mark
Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: Evidence from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort
(
- Contribution to journal › Article
- 2013
-
Mark
Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.
(
- Contribution to journal › Article
-
Mark
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer
(
- Contribution to journal › Article
- 2008
-
Mark
Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions.
(
- Contribution to journal › Article
-
Mark
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers
(
- Contribution to journal › Article
- 2007
-
Mark
A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article